ZTS

NYSE · Pharmaceuticals

Zoetis Inc

S&P 500 Large-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks

$76.68

+2.29 (+3.07%)

As of Aug 6, 9:34 PM ET ·

Analyst Consensus

Hold

Analysts

High

Coverage

Buy 13 54%

Hold 11 46%

Sell 0 0%

Price Target

Analyst Price Target +173.7% upside

Low Target $137.04

Average Target $209.87

High Target $267.95

Current Price $76.68

Current
$76.68

Target
$209.87

$137.04 $209.87 avg $267.95

Scenario Analysis

Bear Case

$137.04

78.7%

Low target

Base Case

$209.87

+173.7%

Avg target

Bull Case

$267.95

+249.5%

High target

Risk/Reward

3.2x

Highly favorable

Price in Context

52-Week High

$160.48

-52.2% from high

52-Week Low

$71.47

+7.3% from low

50-Day SMA

$124.55

-38.4% vs SMA

200-Day SMA

$142.48

-46.2% vs SMA

RSI (14)

62.1

Neutral

Target vs 52W High

$209.87

+30.8% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+11.9%
RDY Dr. Reddy's Laboratories	Sell	44	52%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	68%	$299.55	+16.5%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+23.8%
PFE Pfizer Inc.	Hold	36	42%	$33.90	+30.5%
BMY Bristol-Myers Squibb Co	Hold	35	40%	$174.50	+172.3%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-36.7%
ZTS Zoetis Inc	Hold	24	54%	$209.87	+173.7%